tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Ownership - Who Owns Phathom Pharmaceuticals?

Compare
587 Followers

Phathom Pharmaceuticals (PHAT) Ownership Overview

10.91%10.35%0.21%8.27%70.26%
10.91% Insiders
0.21% Other Institutional Investors
8.27% ETFs
70.26% Public Companies and Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 18.83% of the company’s stock is owned by Institutional Investors, 10.91% is owned by Insiders, and 70.26% is owned by Public Companies and Individual Investors.
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 10.56% of the company’s stock is owned by Institutional Investors, 10.91% is owned by Insiders, and 8.27% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 05, 2025
xxxxxxxxxxxxx
$7079
Sep 09, 2025
xxxxxxxxxxxxx
$5573
Jul 18, 2025
xxxxxxxxxxxxx
$14145
May 23, 2025
xxxxxxxxxxxxx
$14591

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$1042139

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,933,327Insider7.58%89,830,571
2,872,674Institution3.67%43,492,284
2,479,535Institution3.17%37,540,160
2,065,792Institution2.64%31,276,091
1,461,877Institution1.87%22,132,818
1,101,868Insider1.41%16,682,282
746,710Institution0.95%11,305,189
626,862Institution0.80%9,490,691
600,000Institution0.77%9,084,000
481,893Institution0.62%7,295,860

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,479,535Institution3.17%37,540,160
1,461,877Institution1.87%22,132,818
746,710Institution0.95%11,305,189
626,862Institution0.80%9,490,691
481,893Institution0.62%7,295,860
468,977Institution0.60%7,100,312
464,839Institution0.59%7,037,662
262,589Institution0.34%3,975,597
230,274Institution0.29%3,486,348
221,065Institution0.28%3,346,924

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,910,697Institution2.44%29,845,087
986,430Institution1.26%14,934,550
488,599Institution0.62%7,631,916
377,888Institution0.48%5,721,224
321,935Institution0.41%5,031,844
304,589Institution0.39%4,611,477
260,068Institution0.33%4,064,863
248,690Institution0.32%3,765,167
220,064Institution0.28%3,439,600
207,986Institution0.27%3,248,741

FAQ

Who Owns Phathom Pharmaceuticals, Inc. (PHAT)?
According to the latest TipRanks data, approximately 0.21% of the company's stock is held by institutional investors, 10.91% is held by insiders, and 70.26% is held by retail investors.
    What percentage of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.21% of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by institutional investors.
      What percentage of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 70.26% of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by retail investors.
        Who owns the most shares of Phathom Pharmaceuticals, Inc. (PHAT)?
        James Topper owns the most shares of Phathom Pharmaceuticals, Inc. (PHAT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.